These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 31402496)
1. mTOR and other effector kinase signals that impact T cell function and activity. Myers DR; Wheeler B; Roose JP Immunol Rev; 2019 Sep; 291(1):134-153. PubMed ID: 31402496 [TBL] [Abstract][Full Text] [Related]
2. mTOR signaling at the crossroads of environmental signals and T-cell fate decisions. Huang H; Long L; Zhou P; Chapman NM; Chi H Immunol Rev; 2020 May; 295(1):15-38. PubMed ID: 32212344 [TBL] [Abstract][Full Text] [Related]
3. The role and regulation of mTOR in T-lymphocyte function. O'Brien TF; Zhong XP Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):173-81. PubMed ID: 22484804 [TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. Waickman AT; Powell JD J Immunol; 2012 May; 188(10):4721-9. PubMed ID: 22556133 [TBL] [Abstract][Full Text] [Related]
5. mTOR signaling in the differentiation and function of regulatory and effector T cells. Zeng H; Chi H Curr Opin Immunol; 2017 Jun; 46():103-111. PubMed ID: 28535458 [TBL] [Abstract][Full Text] [Related]
6. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells. Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562 [TBL] [Abstract][Full Text] [Related]
7. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation. McQueen B; Trace K; Whitman E; Bedsworth T; Barber A Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells. Kerstan A; Hünig T J Immunol; 2004 Feb; 172(3):1341-5. PubMed ID: 14734708 [TBL] [Abstract][Full Text] [Related]
9. Kidins220/ARMS associates with B-Raf and the TCR, promoting sustained Erk signaling in T cells. Deswal S; Meyer A; Fiala GJ; Eisenhardt AE; Schmitt LC; Salek M; Brummer T; Acuto O; Schamel WW J Immunol; 2013 Mar; 190(5):1927-35. PubMed ID: 23359496 [TBL] [Abstract][Full Text] [Related]
10. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses. Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559 [TBL] [Abstract][Full Text] [Related]
11. The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Miskov-Zivanov N; Turner MS; Kane LP; Morel PA; Faeder JR Sci Signal; 2013 Nov; 6(300):ra97. PubMed ID: 24194584 [TBL] [Abstract][Full Text] [Related]
12. SWAP-70-like adapter of T cells: a novel Lck-regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca2+ signaling in T cells. Bécart S; Altman A Immunol Rev; 2009 Nov; 232(1):319-33. PubMed ID: 19909373 [TBL] [Abstract][Full Text] [Related]
13. Visualizing TCR-induced POLKADOTS formation and NF-κB activation in the D10 T-cell clone and mouse primary effector T cells. Paul S; Schaefer BC Methods Mol Biol; 2015; 1280():219-38. PubMed ID: 25736751 [TBL] [Abstract][Full Text] [Related]
14. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation. Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496 [TBL] [Abstract][Full Text] [Related]
15. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway. Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563 [TBL] [Abstract][Full Text] [Related]
16. The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4 Wang P; Zhang Q; Tan L; Xu Y; Xie X; Zhao Y J Immunol Res; 2020; 2020():3406032. PubMed ID: 32377533 [TBL] [Abstract][Full Text] [Related]
17. mTOR signaling in T cell immunity and autoimmunity. Liu Y; Zhang DT; Liu XG Int Rev Immunol; 2015 Jan; 34(1):50-66. PubMed ID: 25019278 [TBL] [Abstract][Full Text] [Related]
18. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain. Finney HM; Akbar AN; Lawson AD J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway. van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386 [TBL] [Abstract][Full Text] [Related]
20. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. Harlin H; Podack E; Boothby M; Alegre ML J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]